Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - rabeprazole sodium - gastro-resistant tablet - rabeprazole sodium 10 mg - drugs for acid related disorders

Malta - English - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - rabeprazole sodium - gastro-resistant tablet - rabeprazole sodium 20 mg - drugs for acid related disorders

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - rabeprazole sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - rabeprazole sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - rabeprazole sodium, quantity: 10 mg - tablet, enteric coated - excipient ingredients: hyprolose; diacetylated monoglycerides; crospovidone; magnesium stearate; purified talc; hypromellose phthalate; ethylcellulose; light magnesium oxide; mannitol; titanium dioxide; heavy magnesium oxide - indicated for: ,? treatment and prevention of relapse of gastro-oesophageal reflux disease ,? symptomatic treatment of gastro-oesophageal reflux disease ,? treatment of duodenal ulcers ,? treatment of gastric ulcers. ,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. ,also indicated, in combination with clarithromycin and amoxycillin, for: ,? eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis ,? healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - rabeprazole sodium, quantity: 20 mg - tablet, enteric coated - excipient ingredients: diacetylated monoglycerides; heavy magnesium oxide; light magnesium oxide; hyprolose; ethylcellulose; magnesium stearate; purified talc; crospovidone; mannitol; titanium dioxide; hypromellose phthalate; iron oxide yellow - indicated for: ,? treatment and prevention of relapse of gastro-oesophageal reflux disease ,? symptomatic treatment of gastro-oesophageal reflux disease ,? treatment of duodenal ulcers ,? treatment of gastric ulcers. ,patients whose gastric and duodenal ulceration is not associated with ingestion of non-steroidal anti-inflammatory drugs (nsaids) usually require treatment with antimicrobial agents in addition to antisecretory drugs whether on first presentation or on recurrence. ,also indicated, in combination with clarithromycin and amoxycillin, for: ,? eradication of helicobacter pylori in patients with peptic ulcer disease or chronic gastritis ,? healing of peptic ulcers in patients with helicobacter pylori associated ulcers.

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - rabeprazole sodium - tablets gastro-resistant - 10 milligram - rabeprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare limited - rabeprazole sodium - tablets gastro-resistant - 20 milligram - rabeprazole

Canada - English - Health Canada

sanis health inc - rabeprazole sodium - tablet (enteric-coated) - 10mg - rabeprazole sodium 10mg - proton-pump inhibitors

Canada - English - Health Canada

sanis health inc - rabeprazole sodium - tablet (enteric-coated) - 20mg - rabeprazole sodium 20mg - proton-pump inhibitors